Medical Marijuana ProCon.org HOME | CLOSE

1. Name: Dennis M. Israelski, M.D.
2. Title: Former Chief, Infectious Diseases & AIDS Medicine, Clinical Associate Professor, Stanford University School of Medicine
3. Medical Marijuana
Position:		 Pro to the question "Should marijuana be a medical option?"
4. Reasoning:

"[I]t is clear that there are people who use marijuana solely to ameliorate symptoms associated with chronic disease, such as HIV/AIDS. This suggests that cannabinoids have potential benefit as a therapeutic class of agents."
Feb., 2004
5. Credibility
Ranking:

 Key Experts
Physicians [We believe physicians are the "key experts" in the medical marijuana debate because the issue is thought by many to be ultimately based on the medical value and risks of marijuana, and Physicians, with their training and clinical work, should (at least in theory) have the best knowledge of marijuana's medical value and risks.].

6. Involvement:
  • Board of Directors, United States Doctors for Africa, Inc.
  • Former Medical Marijuana Researcher, Center for Medicinal Cannabis Research, San Mateo, CA
  • Former Clinical Professor of Infectious Diseases, Stanford University School of Medicine, California
  • Former President and Executive Director, World Wide Aids Coalition
  • Former Medical Director, AIDS Empowerment and Treatment International, a nongovernmental organization
  • Former Medical Director, San Mateo County AIDS Program
7. Education:
  • M.D., Albert Einstein College of Medicine of Yeshiva University, 1981
    		•
    8. Relevant Affiliations/Honors: None found
    9. Contact Info:
    Phone: (650) 573-2385 Fax: (650) 573-2950
    E-Mail:   None listed
    Web Site: San Mateo Cnty Med Cntr
    10. Other: Some of his publications include:

    • "Marijuana Use and Its Association With Adherence to Antiretroviral Therapy Among Hiv-Infected Persons With Moderate To Severe Nausea"  (PDF 72KB) (with de Jong, B.C., Prentiss, D., McFarland, W., Machekano, R., and Israelski, D.M.), Journal of Acquired Immune Deficiency Syndrome, 2005, 38, (1), 43-46.

    • "Sleep disturbances among HIV-positive adults: the role of pain, stress, and social support," (with Vosvick M, Gore-Felton C, Ashton E, Koopman C, Fluery T, Spiegel D), J Psychosom Res. 2004; 57: 5: 459-63

    • "Mutation Patterns and Structural Correlates in Human Immunodeficiency Virus Type 1 Protease Following Different Protease Inhibitor Treatments," (with Wu TD, Schiffer CA, Gonzales MJ, Taylor J, Kantor R, Chou S, Zolopa AR, Fessel WJ, Shafer RW ), J Virol 2003; 77: 8: 4836-47

    • "Extended Spectrum of Hiv-1 Reverse Transcriptase Mutations in Patients Receiving Multiple Nucleoside Analog Inhibitors," (with Gonzales MJ, Wu TD, Taylor J, Belitskaya I, Kantor R, Chou S, Zolopa AR, Fessel WJ, Shafer RW ), AIDS 2003; 17: 6: 791-9

    • "Evolution of Primary Protease Inhibitor Resistance Mutations During Protease Inhibitor Salvage Therapy," (with Kantor R, Fessel WJ, Zolopa AR, Shulman N, Montoya JG, Harbour M, Schapiro JM, Shafer RW ), Antimicrob Agents Chemotherapy 2002; 46: 4: 1086-92
    HOME | CLOSE